These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24935062)
1. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062 [TBL] [Abstract][Full Text] [Related]
2. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas. Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768 [TBL] [Abstract][Full Text] [Related]
3. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2. Li Y; Zhang X; Chen D; Ma C Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma. He J; Deng Y; Yang G; Xie W J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496 [TBL] [Abstract][Full Text] [Related]
5. Stratifin expression is a novel prognostic factor in human gliomas. Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111 [TBL] [Abstract][Full Text] [Related]
6. [Changes of folate receptor -α protein expression in human gliomas and its clinical relevance]. Wu H; Zhan Y; Qu Y; Qi X; Li J; Yu C Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):202-7. PubMed ID: 24785460 [TBL] [Abstract][Full Text] [Related]
8. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
9. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma. Lee CT; Wu TT; Lohse CM; Zhang L Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603 [TBL] [Abstract][Full Text] [Related]
10. Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype. Wang H; Wang Y; Jiang C Int J Oncol; 2013 May; 42(5):1716-24. PubMed ID: 23467707 [TBL] [Abstract][Full Text] [Related]
11. RIZ1: a potential tumor suppressor in glioma. Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953 [TBL] [Abstract][Full Text] [Related]
12. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
13. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas. Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602 [TBL] [Abstract][Full Text] [Related]
15. High mobility group I-C protein in astrocytoma and glioblastoma. Akai T; Ueda Y; Sasagawa Y; Hamada T; Date T; Katsuda S; Iizuka H; Okada Y; Chada K Pathol Res Pract; 2004; 200(9):619-24. PubMed ID: 15497774 [TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro. Lei X; Chang L; Ye W; Jiang C; Zhang Z Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735 [TBL] [Abstract][Full Text] [Related]
17. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma. Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544 [TBL] [Abstract][Full Text] [Related]
18. Gab2 expression in glioma and its implications for tumor invasion. Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021 [TBL] [Abstract][Full Text] [Related]
19. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330 [TBL] [Abstract][Full Text] [Related]
20. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis. Pang B; Fan H; Zhang IY; Liu B; Feng B; Meng L; Zhang R; Sadeghi S; Guo H; Pang Q J Neurooncol; 2012 Feb; 106(3):543-9. PubMed ID: 21984063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]